Journal Articles
European Journal of Cancer
Year : 2021
Isabelle Bernard-Pierrot : Connect in order to contact the contributor
https://cnrs.hal.science/hal-03453779
Submitted on : Sunday, November 28, 2021-7:23:19 PM
Last modification on : Monday, November 29, 2021-3:06:18 AM
Cite
Clarice Groeneveld, Jacqueline Fontugne, Luc Cabel, Isabelle Bernard-Pierrot, François Radvanyi, et al.. Tertiary lymphoid structures marker CXCL13 is associated with better survival for patients with advanced-stage bladder cancer treated with immunotherapy. European Journal of Cancer, 2021, 148, pp.181-189. ⟨10.1016/j.ejca.2021.01.036⟩. ⟨hal-03453779⟩
12
View
0
Download